Andrew R. Boll - Jan 2, 2023 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role: Chief Financial Officer
Signature: /s/ Andrew R. Boll
Stock symbol: HROW
Transactions as of: Jan 2, 2023
Transactions value $: -$141,726
Form type: 4
Date filed: 1/3/2023, 08:53 PM
Previous filing: Dec 23, 2022
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HROW	Common Stock	Options Exercise		+23K	+9.02%		278K	Jan 2, 2023	Direct	F1
transaction	HROW	Common Stock	Tax liability	-$142K	-9.6K	-3.45%	$14.76	268K	Jan 2, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HROW	Restricted Stock Unit	Options Exercise	$0	-23K	-100%	$0.00^*	0	Jan 2, 2023	Common Stock	23K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The listed Acquired (as described in the table above) 23,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Boll under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs vested in full on January 2, 2023, the third-year anniversary of the grant of the same, and settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 9,602 shares of Harrow common stock were not sold by Mr. Boll in any transaction; rather, they were shares of Harrow common stock withheld from the same aforementioned 23,000 share RSU issuance, by the Company, for payroll tax purposes only.

Content

The listed Acquired (as described in the table above) 23,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Boll under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs vested in full on January 2, 2023, the third-year anniversary of the grant of the same, and settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 9,602 shares of Harrow common stock were not sold by Mr. Boll in any transaction; rather, they were shares of Harrow common stock withheld from the same aforementioned 23,000 share RSU issuance, by the Company, for payroll tax purposes only.